130 related articles for article (PubMed ID: 16357789)
1. Patterns of prescription of hypoglycaemic drugs in Gran Canaria (Canary islands, Spain) and estimation of the prevalence of diabetes mellitus.
de Pablos-Velasco PL; Martínez-Martín FJ; Molero R; Rodríguez-Perez F; García-Puente I; Caballero A
Diabetes Metab; 2005 Nov; 31(5):457-62. PubMed ID: 16357789
[TBL] [Abstract][Full Text] [Related]
2. A prevalence study of known diabetes mellitus in Tuscany assessed from pharmaceutical prescriptions and other independent sources.
Di Cianni G; Benzi L; Giannarelli R; Orsini P; Villani G; Ciccarone AM; Cecchetti P; Fedele O; Navalesi R
Acta Diabetol; 1994 Jun; 31(2):87-90. PubMed ID: 7949228
[TBL] [Abstract][Full Text] [Related]
3. [Drug consumption in diabetes mellitus (I). Estimate of the therapeutic profile and the prevalence in the regions of Tarragona (548,900 inhabitants). Grup per a l'Estudi de la Diabetis a Tarragona].
Costa B; Utgés P; Monclús JF; Gomis T; Ciurana MR; Julve P
Med Clin (Barc); 1992 Sep; 99(8):294-9. PubMed ID: 1453822
[TBL] [Abstract][Full Text] [Related]
4. [A 50-year history of new drugs in Japan-the development and progress of anti-diabetic drugs and the epidemiological aspects of diabetes mellitus].
Ozawa H; Murai Y; Ozawa T
Yakushigaku Zasshi; 2003; 38(1):11-27. PubMed ID: 14570054
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus and impaired glucose regulation in the Canary Islands (Spain): prevalence and associated factors in the adult population of Telde, Gran Canaria.
Boronat M; Varillas VF; Saavedra P; Suárez V; Bosch E; Carrillo A; Nóvoa FJ
Diabet Med; 2006 Feb; 23(2):148-55. PubMed ID: 16433712
[TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus in north Sweden: prevalence assessed from prescriptions for anti-diabetic agents.
Forrest RD
J Intern Med; 1990 Sep; 228(3):267-73. PubMed ID: 2205705
[TBL] [Abstract][Full Text] [Related]
7. [Prevalence of diabetes treated with drugs in Andalucía. Evolution of the oral antidiabetics and insulin prescription between 1994 and 2000].
Torrecilla Rojas MA; Ríos Bonin C; Fernández Fernández I
Rev Clin Esp; 2003 Sep; 203(9):426-9. PubMed ID: 14563255
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence and consumption of medication in diabetes mellitus in Madrid (1996-2002)].
Arrieta FJ; Calvo MJ; Peréz A; Saavedra P; Cordobés FJ; Cabral R; Arrieta JJ; Rovira A
Rev Clin Esp; 2006 Mar; 206(3):117-21. PubMed ID: 16597376
[TBL] [Abstract][Full Text] [Related]
9. Diffusion into use of exenatide for glucose control in diabetes mellitus: a retrospective cohort study of a new therapy.
Segal JB; Dy SM; Millman EA; Herbert R; Bass EB; Wu A
Clin Ther; 2007 Aug; 29(8):1784-94. PubMed ID: 17919559
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and association of co-morbidities in diabetic patients along with prescription patterns in Delhi-NCT, India.
Saxena T; Malhotra M; Yadav RK; Gupta SK
Diabetes Metab Syndr; 2019; 13(2):1209-1212. PubMed ID: 31336466
[TBL] [Abstract][Full Text] [Related]
11. [Drug prescriptions and demographic indicators in a diabetic population in Argentina].
Quaglia NB; Nuñez MH; Marzi MM
Farm Hosp; 2012; 36(2):92-6. PubMed ID: 22047667
[TBL] [Abstract][Full Text] [Related]
12. Disproportionately high incidence of diabetes-related end-stage renal disease in the Canary Islands. An analysis based on estimated population at risk.
Lorenzo V; Boronat M; Saavedra P; Rufino M; Maceira B; Novoa FJ; Torres A
Nephrol Dial Transplant; 2010 Jul; 25(7):2283-8. PubMed ID: 20064954
[TBL] [Abstract][Full Text] [Related]
13. Changes in diabetes prevalence and treatment in the last ten years in Luxembourg. A lesson from the United Kingdom prospective diabetes study?
Perquin M; Michel GH; de Beaufort C; Keipes M; Wirion R; Haas N
Diabetes Metab; 2005 Nov; 31(5):499-502. PubMed ID: 16357795
[TBL] [Abstract][Full Text] [Related]
14. The incidence of skin melanoma in Gran Canaria (Canary Islands, Spain) is lower than expected in Southern Europe despite high-risk environmental conditions: an island-wide cross-sectional study.
Grau-Pérez M; Carretero G; Almeida P; Castro-González E; de-la-Rosa-Del-Rey MDP; González-Martín JM; Borrego L
Cancer Causes Control; 2021 May; 32(5):525-535. PubMed ID: 33646461
[TBL] [Abstract][Full Text] [Related]
15. Prescription of insulin glargine in primary care practices in Germany.
Rathmann W; Haastert B; Riebel P; Schroeder-Bernhardi D; Kostev K; Huppertz E; Giani G
Exp Clin Endocrinol Diabetes; 2007 Apr; 115(4):252-6. PubMed ID: 17479442
[TBL] [Abstract][Full Text] [Related]
16. Repaglinide : a pharmacoeconomic review of its use in type 2 diabetes mellitus.
Plosker GL; Figgitt DP
Pharmacoeconomics; 2004; 22(6):389-411. PubMed ID: 15099124
[TBL] [Abstract][Full Text] [Related]
17. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of the metabolic syndrome in the island of Gran Canaria: comparison of three major diagnostic proposals.
Boronat M; Chirino R; Varillas VF; Saavedra P; Marrero D; Fábregas M; Nóvoa FJ
Diabet Med; 2005 Dec; 22(12):1751-6. PubMed ID: 16401323
[TBL] [Abstract][Full Text] [Related]
19. Diabetes mellitus: new drugs for a new epidemic.
Nicholson G; Hall GM
Br J Anaesth; 2011 Jul; 107(1):65-73. PubMed ID: 21610015
[TBL] [Abstract][Full Text] [Related]
20. Management of diabetes mellitus and patients' attitude towards the disease: Data from a nationwide study in Greece.
Tentolouris A; Eleftheriadou I; Tzeravini E; Athanasakis K; Anastasiou IA; Kyriopoulos J; Tentolouris N
Diabetes Metab Syndr; 2019; 13(2):1159-1164. PubMed ID: 31336459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
